Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study

Abstract

Long-term visit-to-visit glycemic variability is an additional and frequently a better glycemic parameter than mean HbA_1c levels for assessing the risk of future development of micro- and macrovascular complications in patients with type 2 diabetes.